Wall Street brokerages forecast that Teligent (NASDAQ:TLGT) will announce earnings per share (EPS) of ($0.03) for the current quarter, Zacks reports. Three analysts have made estimates for Teligent’s earnings. Teligent reported earnings of $0.07 per share during the same quarter last year, which would indicate a negative year over year growth rate of 142.9%. The firm is expected to announce its next earnings results on Tuesday, May 1st.
According to Zacks, analysts expect that Teligent will report full-year earnings of $0.03 per share for the current year, with EPS estimates ranging from $0.00 to $0.05. For the next fiscal year, analysts anticipate that the company will post earnings of $0.22 per share, with EPS estimates ranging from $0.20 to $0.24. Zacks Investment Research’s earnings per share averages are an average based on a survey of analysts that follow Teligent.
Teligent (NASDAQ:TLGT) last issued its earnings results on Thursday, March 15th. The company reported ($0.08) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.13) by $0.05. Teligent had a negative return on equity of 14.55% and a negative net margin of 18.42%. The company had revenue of $16.10 million during the quarter, compared to the consensus estimate of $13.54 million.
A number of equities analysts have commented on TLGT shares. Canaccord Genuity decreased their target price on Teligent from $4.00 to $3.50 and set a “hold” rating for the company in a research note on Friday, March 2nd. Zacks Investment Research upgraded Teligent from a “sell” rating to a “hold” rating in a research note on Tuesday, March 13th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the stock. Teligent currently has an average rating of “Hold” and an average target price of $7.00.
TLGT stock traded up $0.06 during midday trading on Monday, reaching $2.92. The company had a trading volume of 74,905 shares, compared to its average volume of 625,064. The company has a quick ratio of 2.01, a current ratio of 2.68 and a debt-to-equity ratio of 2.70. Teligent has a fifty-two week low of $2.43 and a fifty-two week high of $9.54. The company has a market cap of $153.00, a P/E ratio of -15.21 and a beta of 0.72.
Several hedge funds and other institutional investors have recently modified their holdings of the company. AMI Asset Management Corp boosted its position in shares of Teligent by 46.4% during the fourth quarter. AMI Asset Management Corp now owns 2,339,968 shares of the company’s stock worth $8,494,000 after buying an additional 741,818 shares during the period. Broadfin Capital LLC boosted its position in shares of Teligent by 35.1% during the fourth quarter. Broadfin Capital LLC now owns 1,925,415 shares of the company’s stock worth $6,989,000 after buying an additional 500,000 shares during the period. Kopp Investment Advisors LLC lifted its position in Teligent by 24.2% in the fourth quarter. Kopp Investment Advisors LLC now owns 956,526 shares of the company’s stock worth $3,472,000 after purchasing an additional 186,390 shares during the period. Guggenheim Capital LLC lifted its position in Teligent by 86.6% in the fourth quarter. Guggenheim Capital LLC now owns 352,934 shares of the company’s stock worth $1,281,000 after purchasing an additional 163,817 shares during the period. Finally, Teachers Advisors LLC lifted its position in Teligent by 24.9% in the fourth quarter. Teachers Advisors LLC now owns 93,152 shares of the company’s stock worth $338,000 after purchasing an additional 18,587 shares during the period. Institutional investors and hedge funds own 68.24% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Teligent (TLGT) Expected to Post Earnings of -$0.03 Per Share” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of international copyright legislation. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/16/teligent-tlgt-expected-to-post-earnings-of-0-03-per-share.html.
Teligent Company Profile
Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.
Get a free copy of the Zacks research report on Teligent (TLGT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.